242 related articles for article (PubMed ID: 2168976)
1. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.
Christodoulou C; Colbere-Garapin F; Macadam A; Taffs LF; Marsden S; Minor P; Horaud F
J Virol; 1990 Oct; 64(10):4922-9. PubMed ID: 2168976
[TBL] [Abstract][Full Text] [Related]
2. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
3. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
5. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of the attenuation phenotype of poliovirus type 1.
Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
[TBL] [Abstract][Full Text] [Related]
7. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
8. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
9. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.
McGoldrick A; Macadam AJ; Dunn G; Rowe A; Burlison J; Minor PD; Meredith J; Evans DJ; Almond JW
J Virol; 1995 Dec; 69(12):7601-5. PubMed ID: 7494267
[TBL] [Abstract][Full Text] [Related]
10. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
Bouchard MJ; Lam DH; Racaniello VR
J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
[TBL] [Abstract][Full Text] [Related]
11. Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome.
Iizuka N; Kohara M; Hagino-Yamagishi K; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Dec; 63(12):5354-63. PubMed ID: 2555560
[TBL] [Abstract][Full Text] [Related]
12. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
[TBL] [Abstract][Full Text] [Related]
14. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
[TBL] [Abstract][Full Text] [Related]
15. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
[TBL] [Abstract][Full Text] [Related]
16. Towards development of an in vitro translation test for poliovirus neurovirulence.
Svitkin YV; Alpatova GA; Lipskaya GA; Maslova SV; Agol VI; Kew O; Meerovitch K; Sonenberg N
Dev Biol Stand; 1993; 78():27-32. PubMed ID: 8388829
[TBL] [Abstract][Full Text] [Related]
17. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.
Pollard SR; Dunn G; Cammack N; Minor PD; Almond JW
J Virol; 1989 Nov; 63(11):4949-51. PubMed ID: 2552175
[TBL] [Abstract][Full Text] [Related]
19. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA.
Shiroki K; Ishii T; Aoki T; Ota Y; Yang WX; Komatsu T; Ami Y; Arita M; Abe S; Hashizume S; Nomoto A
J Virol; 1997 Jan; 71(1):1-8. PubMed ID: 8985316
[TBL] [Abstract][Full Text] [Related]
20. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
Kohara M; Abe S; Yoshioka I; Nomoto A
Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
